Epidemiologie des benignen Prostatasyndroms-Reference-Cited by-同舟云学术

Epidemiologie des benignen Prostatasyndroms

Published:2008-01-31 Issue:2 Volume:47 Page:141-148
ISSN:0340-2592
Container-title:Der Urologe
language:de
Short-container-title:Urologe

Author:

Berges R.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00120-008-1624-6.pdf

Reference26 articles.

1. Berges R (2004) The impact of treatment on lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) progression. Eur Urol Suppl 3: 12–17

2. Berges R (2003) Impact of therapy used in clinical practice on lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) disease progression. Eur Urol Suppl 2: 19–24

3. Berges R, Kühne K, Cubick G et al. (2001) Prevalence of lower urinary tract symptoms (LUTS) related to benign prostatic enlargement (BPE) and their impact on health care seeking. J Urol 165: 266

4. Berges R, Kühne K, Cubick G et al. (2002) Prävalenz von prostatabedingten Miktionsbeschwerden bei Deutschen Männern im Alter über 50 Lebensjahren. Die Herner LUTS-Studie. Urologe A Suppl 1: 47A

5. Berges R, Pientka L, Hofner K et al. (2001) Male lower urinary tract symptoms and related health care seeking in Germany. Eur Urol 39: 682–687

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The oxytocin antagonist cligosiban reduces human prostate contractility: Implications for the treatment of benign prostatic hyperplasia;British Journal of Pharmacology;2024-04-27

2. Prevention of Benign Prostate Syndrome;Benign Prostate Syndrome;2023

3. Epidemiology;Benign Prostate Syndrome;2023

4. The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?;Virchows Archiv;2022-06-17

5. Prävention des Benignen Prostatasyndroms;Benignes Prostatasyndrom;2022